Evaluating the efficacy of commercially available antisense oligonucleotides to reduce mouse and human tau in vivo https://www.biorxiv.org/content/10.1101/2022.12.29.522258v1?med=mas
Evaluating the efficacy of commercially available antisense oligonucleotides to reduce mouse and human tau in vivo https://www.biorxiv.org/content/10.1101/2022.12.29.522258v1?med=mas